Athlete's Foot Types and Treatments

Table of Contents
View All
Table of Contents

The feet are the parts of the body that are most commonly infected by certain fungi called dermatophytes. When this happens, the result is called tinea pedis or athlete’s foot.

Athlete’s foot, from acute vesicular to chronic, is a very common problem that's experienced by up to 70% of the population at some point in life.

Toe and nail fungus. Woman at a dermatologist.
robertprzybysz / Getty Images

Who Is Most at Risk?

Athlete’s foot is common in adult males and uncommon in women. Athlete’s foot can also affect children before puberty, regardless of sex.

Athlete’s foot seems to occur most often in people who have immune systems that predispose them to infection, no matter how many precautions they take.

Once an athlete's foot infection is established, the person becomes a carrier and is more susceptible to recurrences and complications.


Athlete’s foot is divided into three categories:

  • Chronic interdigital athlete’s foot
  • Chronic scaly athlete’s foot (moccasin-type)
  • Acute vesicular athlete’s foot

Chronic Interdigital Athlete’s Foot

This is the most common type of athlete’s foot. It is characterized by scaling, maceration, and fissures most commonly in the webbed space between the fourth and fifth toes.

Tight-fitting, non-porous shoes compress the toes, creating a warm, moist environment in the webbed spaces. Many times, the infecting fungus interacts with bacteria, causing a more severe infection that extends onto the foot.

In chronic interdigital athlete’s foot, itching is typically most intense when the socks and shoes are removed.

Chronic Scaly (Moccasin-Type) Athlete’s Foot

This type of athlete’s foot is caused by Trichophyton rubrum. This dermatophyte causes dry, scaling skin on the sole of the foot. The scale is very fine and silvery, and the skin underneath is usually pink and tender.

The hands may also be infected, although the usual pattern of infection is two feet and one hand, or one foot and two hands.

Chronic scaly athlete’s foot is often seen in people who have eczema or asthma and is associated with fungal nail infections which may lead to recurrent skin infections.

Acute Vesicular Athlete’s Foot

This is the least common type of athlete’s foot, caused by Trichophyton mentagrophytes. It often originates in people who have a chronic interdigital toe web infection.

Acute vesicular athlete’s foot is characterized by the sudden onset of painful blisters on the sole or top of the foot.

Another wave of blisters may follow the first and may also involve other sites of the body such as the arms, chest, or sides of the fingers. These blisters are caused by an allergic reaction to the fungus on the foot—it's called an id reaction. This type of athlete’s foot is also known as “jungle rot,” a historically disabling problem for servicemen fighting in warm, humid conditions.

Diagnosing the Infection

Athlete’s foot is diagnosed by a clinical exam. A doctor usually performs something called a KOH test. A positive KOH test confirms the diagnosis, but a negative KOH test does not mean that a person does not have athlete’s foot. Fungal elements can be difficult to isolate in interdigital and moccasin-type athlete’s foot.


Mild cases of athlete’s foot, especially interdigital toe web infections, can be treated with topical antifungal creams or sprays such as tolnaftate or Lotrimin.

Topical medications should be applied twice a day until the rash is completely resolved.

More serious infections and moccasin-type athlete’s foot should be treated with oral antifungal medications such as terbinafine or itraconazole for two to six months. All oral antifungal medications can affect the liver; therefore, blood tests should be performed monthly to evaluate liver function.

Was this page helpful?
Article Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Abd Elmegeed AS, Ouf SA, Moussa TA, Eltahlawi SM. Dermatophytes and other associated fungi in patients attending to some hospitals in EgyptBraz J Microbiol. 2015;46(3):799–805. doi:10.1590/S1517-838246320140615

  2. Homei A, Worboys M. Fungal Disease in Britain and the United States 1850–2000: Mycoses and Modernity. Basingstoke (UK): Palgrave Macmillan; 2013. Chapter 2, Athlete’s Foot: A Disease of Fitness and Hygiene. Available from:

  3. [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. Nail fungus: Overview. 2015 Jan 14 [Updated 2018 Jun 14].Available from:

  4. [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. Athlete's foot: Overview. 2015 Jan 14 [Updated 2018 Jun 14].Available from:

  5. Nigam PK, Saleh D. Tinea Pedis. [Updated 2019 Nov 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-. Available from:

  6. Leyden JJ, Kligman AM. Interdigital athlete's foot: new concepts in pathogenesis. Postgrad Med. 1977;61(6):113-6.

  7. Blutfield MS, Lohre JM, Pawich DA, Vlahovic TC. The Immunologic Response to Trichophyton Rubrum in Lower Extremity Fungal InfectionsJ Fungi (Basel). 2015;1(2):130–137. doi:10.3390/jof1020130

  8. Al Hasan M, Fitzgerald SM, Saoudian M, Krishnaswamy G. Dermatology for the practicing allergist: Tinea pedis and its complicationsClin Mol Allergy. 2004;2(1):5. Published 2004 Mar 29. doi:10.1186/1476-7961-2-5

  9. Chollet A, Cattin V, Fratti M, Mignon B, Monod M. Which Fungus Originally was Trichophyton mentagrophytes? Historical Review and Illustration by a Clinical Case. Mycopathologia. 2015;180(1-2):1-5. doi:10.1007/s11046-015-9893-2

  10. Newland JG, Abdel-Rahman SM. Update on terbinafine with a focus on dermatophytosesClin Cosmet Investig Dermatol. 2009;2:49–63. Published 2009 Apr 21. doi:10.2147/ccid.s3690

  11. Hainer BL. Dermatophyte infections. Am Fam Physician. 2003;67(1):101-8.

  12. Jimenez-garcia L, Celis-aguilar E, Díaz-pavón G, et al. Efficacy of topical clotrimazole vs. topical tolnaftate in the treatment of otomycosis. A randomized controlled clinical trial. Braz J Otorhinolaryngol. 2019.

  13. Lestner J, Hope WW. Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections. Expert Opin Drug Metab Toxicol. 2013;9(7):911-26.